Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Paushak

WEBSITE BSE:532742 NSE: PAUSHAKLTD Inc. Year: 1972 Industry: Chemicals My Bucket: Add Stock

₹457.2 -13.6 | 2.9%

Last updated: 15:53

Consolidated Standalone

Last updated: 15:53

Paushak Overview

Paushak Ltd is an totally India-based pharmaceutical organisation, that's engaged within the development and production of phosgene-primarily based chemical compounds and intermediates. The Company is engaged within the production of organic intermediates products, such as Isocyanates, which encompass 2-Phenyl Ethyl Isocyanate, 2- Cyclohexyl Isocyanate and Cyclohexyl Isocyanate; Chloroformates, which comprises 2- Ethylhexyl Chloroformate, n-Hexyl Chloroformate, Isobutyl Chloroformate and Para Nitrophenyl Chloroformate; Carbamoyl Chlorides, whic...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Paushak Key Financials

Market Cap ₹1127 Cr.

Stock P/E 22.8

P/B 2.3

Current Price ₹457.2

Book Value ₹ 201

Face Value 5

52W High ₹991.2

Dividend Yield 0.55%

52W Low ₹ 343

Edit Ratio

Paushak Share Price

₹ | |

Volume
Price

Paushak Quarterly Price

Quarterly Monthly
Show Value Show %

Paushak Peer Comparison

Paushak Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 52 52 54 52 57 49 52 56 59 49
Other Income 7 3 7 4 4 6 0 2 1 1
Total Income 59 55 61 56 61 56 52 58 60 50
Total Expenditure 38 33 35 40 40 35 36 38 44 37
Operating Profit 21 22 26 16 21 21 16 20 16 12
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 3 3 4 4 4 4 4 4 4 5
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 18 18 23 12 17 17 12 16 11 7
Provision for Tax 4 5 4 2 3 2 3 4 3 1
Profit After Tax 13 14 18 10 14 15 10 12 9 6
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 13 14 18 10 14 15 10 12 9 6
Adjusted Earnings Per Share 5.4 5.5 7.4 4.2 5.8 6.2 3.9 4.9 3.5 2.5

Paushak Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 69 78 67 103 140 138 141 150 212 206 211 216
Other Income 3 3 5 3 3 5 6 5 9 20 14 4
Total Income 72 81 72 106 142 143 147 155 221 227 225 220
Total Expenditure 52 61 55 74 99 95 91 96 137 142 151 155
Operating Profit 20 19 17 32 43 47 57 59 84 85 74 64
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 3 3 3 4 4 5 9 13 14 15 17
Exceptional Income / Expenses 0 0 0 0 10 2 0 0 2 0 0 0
Profit Before Tax 18 17 14 29 49 45 52 50 72 71 59 46
Provision for Tax 5 4 3 7 10 10 14 13 18 17 9 11
Profit After Tax 13 12 11 21 39 35 37 38 54 54 49 37
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 13 12 11 21 39 35 37 38 54 54 49 37
Adjusted Earnings Per Share 5.1 4.8 4.3 8.4 15.8 14.2 15.1 15.3 21.9 22 20 14.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 2% 12% 9% 12%
Operating Profit CAGR -13% 8% 10% 14%
PAT CAGR -9% 9% 7% 14%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -22% -21% -13% 18%
ROE Average 11% 14% 14% 18%
ROCE Average 13% 18% 18% 23%

Paushak Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 57 69 83 113 178 227 272 306 354 408 465
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 25
Other Non-Current Liabilities 2 2 4 9 22 26 30 34 39 47 37
Total Current Liabilities 9 11 7 22 15 16 27 27 22 26 44
Total Liabilities 69 82 94 144 214 270 329 367 415 481 572
Fixed Assets 18 20 35 37 38 41 51 147 149 152 141
Other Non-Current Assets 12 22 33 52 86 119 183 116 119 113 331
Total Current Assets 38 40 26 56 90 111 95 104 147 216 100
Total Assets 69 82 94 144 214 270 329 367 415 481 572

Paushak Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 1 1 0 0 1 1
Cash Flow from Operating Activities 9 14 12 10 24 45 30 44 43 56 38
Cash Flow from Investing Activities -8 -13 -11 -10 -0 -43 -29 -42 -38 -50 -57
Cash Flow from Financing Activities -1 -1 -2 -1 -23 -2 -2 -2 -4 -5 19
Net Cash Inflow / Outflow 0 0 -0 0 0 0 -1 -0 0 0 -1
Closing Cash & Cash Equivalent 0 0 0 0 1 1 0 0 1 1 0

Paushak Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 5.06 4.84 4.26 8.37 15.8 14.16 15.13 15.25 21.9 22.04 20.03
CEPS(Rs) 5.9 5.93 5.52 9.69 17.37 15.94 17.14 18.91 27.34 27.66 26.1
DPS(Rs) 0.38 0.38 0.38 0.38 0.63 0.75 0.75 1.5 2.19 2.5 2.5
Book NAV/Share(Rs) 22.37 26.76 32.36 44.09 72.01 92.16 110.18 123.93 143.45 165.52 188.79
Core EBITDA Margin(%) 23.59 20.02 16.75 28.02 28.81 31.01 35.79 36.13 35.41 31.27 28.28
EBIT Margin(%) 24.32 19.91 19.6 27.65 35.21 32.96 36.62 33.54 34.16 34.49 27.93
Pre Tax Margin(%) 24.27 19.84 19.52 27.56 35.12 32.9 36.59 33.5 34.01 34.42 27.86
PAT Margin (%) 17.53 14.83 15.13 20.5 27.93 25.32 26.45 25.06 25.43 26.35 23.41
Cash Profit Margin (%) 20.42 18.18 19.57 23.73 30.7 28.49 29.97 31.07 31.75 33.06 30.5
ROA(%) 19.41 16.52 12.43 17.99 21.73 14.43 12.46 10.82 13.83 12.13 9.38
ROE(%) 25.21 19.7 14.43 21.89 26.8 17.25 14.95 13.03 16.38 14.27 11.3
ROCE(%) 34.89 26.29 18.63 29.44 33.73 22.45 20.7 17.44 22 18.68 13.11
Receivable days 88.11 92.19 93.68 95.95 93.12 77.61 76.49 88.33 79.25 91.28 91.01
Inventory Days 36.11 35.28 44.71 36.03 39.24 45.2 38.88 39.84 35.85 39.38 37.55
Payable days 78.5 96.33 94.23 108.65 95.87 98.56 132.67 181.06 134.15 127.37 149.54
PER(x) 9.04 15.28 16.97 19.22 16.04 15.27 69.06 85.18 35.48 28.91 28.19
Price/Book(x) 2.05 2.76 2.24 3.65 3.52 2.35 9.48 10.48 5.42 3.85 2.99
Dividend Yield(%) 0.82 0.51 0.52 0.23 0.25 0.35 0.07 0.12 0.28 0.39 0.44
EV/Net Sales(x) 1.7 2.44 2.78 3.99 4.47 3.86 18.26 21.34 9.02 7.61 6.72
EV/Core EBITDA(x) 5.82 9.75 10.66 12.76 14.57 11.22 45.5 53.96 22.73 18.48 19.17
Net Sales Growth(%) 22.47 12.91 -14.42 55.14 34.89 -1.15 2.24 6.45 41.47 -2.87 2.27
EBIT Growth(%) 41.45 -7.52 -14.96 104.3 69.61 -7.48 13.62 -2.52 44.09 -1.92 -17.19
PAT Growth(%) 47.31 -4.43 -11.88 96.22 81.44 -10.38 6.83 0.84 43.59 0.64 -9.15
EPS Growth(%) 47.31 -4.43 -11.88 96.22 88.8 -10.38 6.83 0.84 43.59 0.64 -9.15
Debt/Equity(x) 0 0.01 0 0.01 0 0 0 0 0 0 0.05
Current Ratio(x) 4.08 3.61 3.69 2.49 6.07 6.81 3.49 3.83 6.6 8.3 2.24
Quick Ratio(x) 3.33 2.78 2.48 1.95 4.86 5.81 2.98 3.13 5.58 7.46 1.75
Interest Cover(x) 461.03 276.45 239.88 295.24 360.16 592.57 1051.69 818.52 233.3 467.13 416.35
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0.02

Paushak Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 66.97 66.97 66.97 66.97 66.97 67.13 67.13 67.28 67.28 67.28
FII 0.02 0.02 0 0 0 0.01 0 0 0 0
DII 0.11 0.2 0.29 0.34 0.4 0.53 0.53 0.71 0.67 0.25
Public 32.9 32.8 32.74 32.69 32.64 32.32 32.33 32.01 32.05 32.47
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Paushak News

Paushak Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 14% over the last 3 years.
  • Debtor days have increased from 127.37 to 149.54days.
  • The company has delivered a poor profit growth of 6% over past five years.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!